NCT05812404View on ClinicalTrials.gov

Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 26, 2022

Primary Completion Date

March 28, 2023

Study Completion Date

June 16, 2023

Conditions
Drug Drug Interaction
Interventions
DRUG

DWP14012

Potassium-competitive acid blocker

DRUG

DWC202201

Atorvastatin Calcium Trihydrate

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY